Fig. 2From: Change of ranibizumab-induced human vitreous protein profile in patients with proliferative diabetic retinopathy based on proteomics analysisA Proteins detected in (a) only PDR group, (b) only control group, (c) both groups, (d) differentially expressed among the proteins detected in both groups. B Proteins detected in (a) only PDR group, (b) only IVR group, (c) both groups, (d) differentially expressed among the proteins detected in both groupsBack to article page